Your browser doesn't support javascript.
loading
Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones.
Ndacayisaba, Libere J; Rappard, Kate E; Shishido, Stephanie N; Ruiz Velasco, Carmen; Matsumoto, Nicholas; Navarez, Rafael; Tang, Guilin; Lin, Pei; Setayesh, Sonia M; Naghdloo, Amin; Hsu, Ching-Ju; Maney, Carlisle; Symer, David; Bethel, Kelly; Kelly, Kevin; Merchant, Akil; Orlowski, Robert; Hicks, James; Mason, Jeremy; Manasanch, Elisabeth E; Kuhn, Peter.
Afiliación
  • Ndacayisaba LJ; Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA 90089, USA.
  • Rappard KE; Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
  • Shishido SN; Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA 90089, USA.
  • Ruiz Velasco C; Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA 90089, USA.
  • Matsumoto N; Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA 90089, USA.
  • Navarez R; Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA 90089, USA.
  • Tang G; Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA 90089, USA.
  • Lin P; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Setayesh SM; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Naghdloo A; Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA 90089, USA.
  • Hsu CJ; Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA 90089, USA.
  • Maney C; Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA 90089, USA.
  • Symer D; Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA 90089, USA.
  • Bethel K; Department of Lymphoma/Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Kelly K; Department of Pathology, Scripps Clinic Medical Group, La Jolla, CA 92037, USA.
  • Merchant A; Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
  • Orlowski R; Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Hicks J; Department of Lymphoma/Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Mason J; Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA 90089, USA.
  • Manasanch EE; Department of Pathology, Scripps Clinic Medical Group, La Jolla, CA 92037, USA.
  • Kuhn P; Convergent Science Institute in Cancer, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, CA 90089, USA.
Curr Oncol ; 29(5): 2954-2972, 2022 04 21.
Article en En | MEDLINE | ID: mdl-35621632
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: Curr Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: Curr Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos